Summary
This NIH funding opportunity under the HEAL (Helping to End Addiction Long-term) Initiative solicits research applications focused on enabling analgesic discovery. The R61/R33 phased award mechanism supports preclinical and translational studies aimed at advancing non-opioid or improved pain treatment options. Clinical trials are explicitly not allowed under this announcement. The opportunity is open for an extended multi-year window, reflecting a standing/reissued funding opportunity announcement (FOA).